Alert: Major Price Decline (3/31/20)-Adverum Biotechnologies Inc (NASDAQ: ADVM).


Adverum Biotechnologies Inc (NASDAQ: ADVM) stock suffered a major decline of -11.1% on 3/31/20. The shares closed at $9.77. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -5.9% during the last week.


Current PriceTarget Research Rating

Reflecting future returns on capital that are forecasted to fall short of the cost of capital, ADVM is expected to continue to be a major Value Eraser.

ADVM has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. ADVM has a very low Appreciation Score of 6 but a good Power Rating of 81, with the Negative Value Trend Rating the result.

Rating Review

In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.

About John Lafferty 98356 Articles
During his career, John has developed valuation and stock rating methodologies, managed institutional portfolios and mutual funds, and provided equity research to institutional investors on thousands of companies. He has been Director of Research at PTR since its inception in 2004.

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.